Technical Analysis for AEZS - Aeterna Zentaris Inc

Grade Last Price % Change Price Change
C 2.670 0.00% 0.000
AEZS closed down 3.26 percent on Thursday, April 18, 2024, on 8 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: May 7
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Down

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Gapped Down Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Bollinger Band Squeeze Range Contraction -3.26%
Narrow Range Bar Range Contraction -3.26%
Gapped Up Strength -3.26%
Oversold Stochastic Weakness -3.26%
Bollinger Band Squeeze Range Contraction -1.11%
Narrow Range Bar Range Contraction -1.11%

   Recent Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Aeterna Zentaris Inc Description

Aeterna Zentaris Inc is a specialty biopharmaceutical company engaged in developing and commercializing treatments in oncology, endocrinology and women's health. The Company operates through the biopharmaceutical segment. The Company is engaged in drug development activities and in the promotion of products for others. The Company's principal product candidates are Zoptrex (zoptarelin doxorubicin) and Macrilen (macimorelin) in oncology and endocrinology. The Company focuses on its product candidates Zoptrex and Macrilen, which are in Phase III clinical development, and on a luteinizing hormone-releasing hormone (LHRH)-disorazol Z conjugate (AEZS-138), which is in pre-clinical development in oncology and is available for partnering. The Company's direct and indirect subsidiaries include AEZS GmbH, Zentaris IVF GmbH and Aeterna Zentaris, Inc.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Health Pharma Pharmaceutical Clinic Drug Biotechnology Leasing Life Sciences Oncology Biopharmaceutical Drug Development Peptides Hormone

Is AEZS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 4.88
52 Week Low 1.91
Average Volume 2,251
200-Day Moving Average 3.019
50-Day Moving Average 2.642
20-Day Moving Average 2.786
10-Day Moving Average 2.751
Average True Range 0.095
RSI (14) 45.36
ADX 33.26
+DI 36.207
-DI 31.750
Chandelier Exit (Long, 3 ATRs) 2.776
Chandelier Exit (Short, 3 ATRs) 2.954
Upper Bollinger Bands 2.922
Lower Bollinger Band 2.649
Percent B (%b) 0.08
BandWidth 9.808
MACD Line 0.011
MACD Signal Line 0.034
MACD Histogram -0.0231
Fundamentals Value
Market Cap 167.35 Million
Num Shares 62.7 Million
EPS -0.75
Price-to-Earnings (P/E) Ratio -3.57
Price-to-Sales 9.61
Price-to-Book 1.71
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.670
Resistance 3 (R3) 2.670 2.670 2.670
Resistance 2 (R2) 2.670 2.670 2.670 2.670
Resistance 1 (R1) 2.670 2.670 2.670 2.670 2.670
Pivot Point 2.670 2.670 2.670 2.670 2.670
Support 1 (S1) 2.670 2.670 2.670 2.670 2.670
Support 2 (S2) 2.670 2.670 2.670 2.670
Support 3 (S3) 2.670 2.670 2.670
Support 4 (S4) 2.670